Phycus Biotechnologies
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$435,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phycus Biotechnologies operates in Energy & Sustainability and is based in Toronto. Its latest recorded funding round was a Grant round in January 2025.
Phycus Biotechnologies is a biotechnology company that develops fermentation-based, bio-based chemical alternatives to petrochemical ingredients for the cosmetics and personal care industries.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phycus Biotechnologies Comparables
Compare Phycus Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lygos | 77% | |
| Geltor | 77% | |
| Debut | 72% |
For institutional investors. Book with your work email.
Phycus Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Grant | Aug 1, 2023 | ||||
| Grant | Jun 1, 2021 | ||||
| Grant | Jul 15, 2020 | ||||
| Grant | Jan 2, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phycus Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sustainable Development Technology Canada | Grant |
| University of Toronto Early Stage Technology | Seed |
| Innovacorp | Seed |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Bioindustrial Innovation Canada | Seed |
| Natural Products Canada | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 42% MoM.
- Jun 2, 2025
Grew 300% QoQ from 1 to 4 employees.
For institutional investors. Book with your work email.
Phycus Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phycus Biotechnologies's valuation, stock price, and market status.
Is Phycus Biotechnologies a public or private company?
Phycus Biotechnologies is a private company.
What is the current stock price of Phycus Biotechnologies?
Phycus Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Phycus Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phycus Biotechnologies worth (valuation)?
Valuation information for Phycus Biotechnologies is not publicly available.
Can I buy Phycus Biotechnologies stock?
Phycus Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phycus Biotechnologies's last funding round?
Phycus Biotechnologies's most recent funding round was Grant on January 1, 2025.
Who are the main investors in Phycus Biotechnologies?
Key investors in Phycus Biotechnologies include Sustainable Development Technology Canada, University of Toronto Early Stage Technology, Innovacorp, National Research Council Canada Industrial Research Assistance Program, Bioindustrial Innovation Canada.
Will Phycus Biotechnologies IPO soon?
No public IPO plans have been announced for Phycus Biotechnologies.
How can I track Phycus Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Phycus Biotechnologies's shares on secondary markets.